The additive Alterion NE® is a preparation containing viable spores of a strain of Bacillus subtilis. The additive is intended for use in feed for chickens for fattening and chickens reared for laying at the proposed dose of 1 9 108 CFU/kg complete feedingstuffs. B. subtilis is considered by EFSA to be suitable for the qualified presumption of safety approach to establish safety. As the identity of the active agent was established and the lack of toxigenic potential and of resistance to antibiotics of human or veterinary clinical significance demonstrated, the additive is presumed safe for the target species, consumers and the environment. Alterion NE® is not a dermal irritant but is irritant to eyes and should be considered a potential respiratory sensitiser. In the absence of data, no conclusion can be drawn on the dermal sensitisation of the additive. Alterion NE® at the recommended dose 1 9 108 CFU/kg feed has the potential to improve the zootechnical performance of chickens for fattening. This conclusion can be extended to chickens reared for laying when used at the same dose. B. subtilis DSM 29784 is compatible with monensin sodium, narasin/nicarbazin, salinomycin sodium, lasalocid sodium, diclazuril, narasin, maduramicin ammonium, robenidine hydrochloride and decoquinate at the highest authorised levels.

Safety and efficacy of Alterion NE® (Bacillus subtilis DSM 29784) as a feed additive for chickens for fattening and chickens reared for laying / G. Rychen, G. Aquilina, G. Azimonti, V. Bampidis, M.D. Bastos, G. Bories, A. Chesson, P.S. Cocconcelli, G. Flachowsky, J. Gropp, B. Kolar, M. Kouba, M. López‐alonso, S. López Puente, A. Mantovani, B. Mayo, F. Ramos, R.E. Villa, R.J. Wallace, P. Wester, R. Brozzi, M. Saarela. - In: EFSA JOURNAL. - ISSN 1831-4732. - 15:7(2017), pp. 4933.1-4933.12. [10.2903/j.efsa.2017.4933]

Safety and efficacy of Alterion NE® (Bacillus subtilis DSM 29784) as a feed additive for chickens for fattening and chickens reared for laying

R.E. Villa;
2017

Abstract

The additive Alterion NE® is a preparation containing viable spores of a strain of Bacillus subtilis. The additive is intended for use in feed for chickens for fattening and chickens reared for laying at the proposed dose of 1 9 108 CFU/kg complete feedingstuffs. B. subtilis is considered by EFSA to be suitable for the qualified presumption of safety approach to establish safety. As the identity of the active agent was established and the lack of toxigenic potential and of resistance to antibiotics of human or veterinary clinical significance demonstrated, the additive is presumed safe for the target species, consumers and the environment. Alterion NE® is not a dermal irritant but is irritant to eyes and should be considered a potential respiratory sensitiser. In the absence of data, no conclusion can be drawn on the dermal sensitisation of the additive. Alterion NE® at the recommended dose 1 9 108 CFU/kg feed has the potential to improve the zootechnical performance of chickens for fattening. This conclusion can be extended to chickens reared for laying when used at the same dose. B. subtilis DSM 29784 is compatible with monensin sodium, narasin/nicarbazin, salinomycin sodium, lasalocid sodium, diclazuril, narasin, maduramicin ammonium, robenidine hydrochloride and decoquinate at the highest authorised levels.
English
Alterion NE®; Bacillus subtilis DSM 29784; zootechnical additive; chickens, safety; QPS; efficacy
Settore VET/07 - Farmacologia e Tossicologia Veterinaria
Articolo
Nessuno
Pubblicazione scientifica
2017
European Food Safety Authority
15
7
4933
1
12
12
Pubblicato
Periodico con rilevanza internazionale
crossref
Aderisco
info:eu-repo/semantics/article
Safety and efficacy of Alterion NE® (Bacillus subtilis DSM 29784) as a feed additive for chickens for fattening and chickens reared for laying / G. Rychen, G. Aquilina, G. Azimonti, V. Bampidis, M.D. Bastos, G. Bories, A. Chesson, P.S. Cocconcelli, G. Flachowsky, J. Gropp, B. Kolar, M. Kouba, M. López‐alonso, S. López Puente, A. Mantovani, B. Mayo, F. Ramos, R.E. Villa, R.J. Wallace, P. Wester, R. Brozzi, M. Saarela. - In: EFSA JOURNAL. - ISSN 1831-4732. - 15:7(2017), pp. 4933.1-4933.12. [10.2903/j.efsa.2017.4933]
open
Prodotti della ricerca::01 - Articolo su periodico
22
262
Article (author)
no
G. Rychen, G. Aquilina, G. Azimonti, V. Bampidis, M.D. Bastos, G. Bories, A. Chesson, P.S. Cocconcelli, G. Flachowsky, J. Gropp, B. Kolar, M. Kouba, M. López‐alonso, S. López Puente, A. Mantovani, B. Mayo, F. Ramos, R.E. Villa, R.J. Wallace, P. Wester, R. Brozzi, M. Saarela
File in questo prodotto:
File Dimensione Formato  
Rychen_et_al-2017-EFSA_Journal (3).pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 774.82 kB
Formato Adobe PDF
774.82 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/566963
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 1
social impact